cannabis indica

Índice completo — página 38 de 77

Estudos 3.701 a 3.800 de 7.640, ordenados do mais recente ao mais antigo — nesta página, publicações de 2019. Para buscar por termo ou combinar filtros, use o acervo com busca.

Estudos 3.701 a 3.800

  1. 2019

    Awareness of Emotional Expressions in Cannabis Users: An Event-Related Potential Study

    InconclusivoMetanáliseAnsiedadeLuto
  2. 2019

    Beliefs and attitudes regarding prenatal marijuana use: Perspectives of pregnant women who report use

    InconclusivoMetanáliseGestação
  3. 2019

    Benefit of Tetrahydrocannabinol versus Cannabidiol for Common Palliative Care Symptoms

    FavorávelMetanáliseDorAnsiedadeDepressão+5
  4. 2019

    Beta-caryophyllene enhances wound healing through multiple routes

    FavorávelEstudo em AnimaisCicatrização
  5. 2019

    Beyond stimulants: a systematic review of randomised controlled trials assessing novel compounds for ADHD

  6. 2019

    Big Five personality traits and alcohol, nicotine, cannabis, and gambling disorder comorbidity

  7. 2019

    Bilateral multiple exudative retinal detachments and macular edema in a patient diagnosed with synthetic cannabinoid (Bonzai) intoxication

  8. 2019

    Bioactive: A new era of bioactive ingredients in topical formulations for inflammatory dermatoses

  9. 2019

    Biologically Active Cannabinoids from High-Potency Cannabis sativa

    FavorávelEstudo LaboratorialInfecções BacterianasInfecções FúngicasMalária+1
  10. 2019

    Bipolar disorder and the endocannabinoid system

    FavorávelMetanáliseTranstorno Bipolar
  11. 2019

    Blood-brain barrier disturbances in diabetes-associated dementia: Therapeutic potential for cannabinoids.

    FavorávelMetanáliseDisfunção CognitivaDiabetes
  12. 2019

    Blunts versus joints: Cannabis use characteristics and consequences among treatment-seeking adults

    FavorávelEnsaio ClínicoDependência QuímicaDependência — Cannabis
  13. 2019

    Bone Anabolic Response in the Calvaria Following Mild Traumatic Brain Injury is Mediated by the Cannabinoid-1 Receptor

    FavorávelEstudo em AnimaisTraumatismo CranioencefálicoAnandamida (AEA)
  14. 2019

    Borneol for Regulating the Permeability of the Blood-Brain Barrier in Experimental Ischemic Stroke: Preclinical Evidence and Possible Mechanism

    FavorávelMetanáliseInflamaçãoEstresse OxidativoAVC
  15. 2019

    Brain-targeted intranasal delivery of dopamine with borneol and lactoferrin co-modified nanoparticles for treating Parkinson’s disease

    FavorávelEstudo LaboratorialDoença de Parkinson
  16. 2019

    Brief Commentary: Marijuana Use During Gestation and Lactation-Harmful Until Proved Safe

    DesfavorávelMetanáliseGestação
  17. 2019

    Brief Report: Cannabidiol-Rich Cannabis in Children with Autism Spectrum Disorder and Severe Behavioral Problems-A Retrospective Feasibility Study

    FavorávelEnsaio ClínicoTranstornos de ComportamentoAutismo
  18. 2019

    Burden of Comorbidities in Hospitalizations for Cannabis Use-associated Intractable Vomiting during Post-legalization Period

  19. 2019

    Burden of Persistent Vomiting With Cannabis Use Disorder: Report From 55,549 Hospitalizations in the United States

  20. 2019

    Can we teach old drugs new tricks?-Repurposing of neuropharmacological drugs for inflammatory skin diseases

    FavorávelMetanáliseInflamaçãoDepressãoEpilepsia+15
  21. 2019

    Can we turn mice into men?: An Editorial for Effects of cannabinoids in Amyotrophic Lateral Sclerosis (ALS) murine models: a systematic review and meta-analysis page 284.

    FavorávelMetanáliseEsclerose Lateral Amiotrófica (ELA)
  22. 2019

    Canadian Association of Gastroenterology Clinical Practice Guideline for the Medical Management of Pediatric Luminal Crohn's Disease

    InconclusivoMetanáliseDII — Doença de Crohn
  23. 2019

    Canadian clinical practice guidelines for the use of plant-based cannabis and cannabinoid-based products in the management of chronic non-cancer pain and co-occurring conditions: protocol for a systematic literature review

    InconclusivoMetanáliseDorAnsiedadeDor — Crônica+2
  24. 2019

    Cannabichromene is a cannabinoid CB2 receptor agonist

  25. 2019

    Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition

    DesfavorávelEnsaio Clínico Duplo-CegoDisfunção CognitivaPsicoseTetraidrocanabinol (THC)
  26. 2019

    Cannabidiol (CBD) Reduces Anxiety-Related Behavior in Mice via an FMRP-independent Mechanism

    FavorávelEstudo em AnimaisSíndrome do X Frágil
  27. 2019

    Cannabidiol (CBD) use in psychiatric disorders: A systematic review.

    InconclusivoMetanáliseAnsiedadePsicoseTEPT
  28. 2019

    Cannabidiol Adverse Effects and Toxicity

  29. 2019

    Cannabidiol Affects the Bezold-Jarisch Reflex via TRPV1 and 5-HT3 Receptors and Has Peripheral Sympathomimetic Effects in Spontaneously Hypertensive and Normotensive Rats

    FavorávelEstudo em AnimaisDoenças Cardiovasculares (DCV)Hipertensão Arterial
  30. 2019

    Cannabidiol and Cannabinoid Compounds as Potential Strategies for Treating Parkinson's Disease and L-DOPA-Induced Dyskinesia.

  31. 2019

    Cannabidiol as a Novel Candidate Alcohol Use Disorder Pharmacotherapy: A Systematic Review

    FavorávelMetanáliseDependência QuímicaDependência — Álcool
  32. 2019

    Cannabidiol As A Novel Therapeutic Strategy For Oral Inflammatory Diseases: A Review Of Current Knowledge And Future Perspectives

    FavorávelMetanáliseInflamaçãoArtriteDII — Doença Inflamatória Intestinal+2
  33. 2019

    Cannabidiol as a potential treatment for psychosis

    FavorávelMetanálisePsicoseEsquizofrenia
  34. 2019

    Cannabidiol as a suggested candidate for treatment of autism spectrum disorder

    FavorávelMetanáliseAutismo
  35. 2019

    Cannabidiol as adjunctive treatment of seizures associated with Lennox-Gastaut syndrome and Dravet syndrome

  36. 2019

    Cannabidiol attenuates aggressive behavior induced by social isolation in mice: Involvement of 5-HT1A and CB1 receptors

    FavorávelEstudo em AnimaisTranstorno Explosivo Intermitente
  37. 2019

    Cannabidiol attenuates insular dysfunction during motivational salience processing in subjects at clinical high risk for psychosis

    FavorávelEnsaio Clínico Duplo-CegoPsicoseEsquizofrenia
  38. 2019

    Cannabidiol directly targets mitochondria and disturbs calcium homeostasis in acute lymphoblastic leukemia

    FavorávelEstudo LaboratorialCâncerCâncer — Leucemia
  39. 2019

    Cannabidiol for the Reduction of Cue-Induced Craving and Anxiety in Drug-Abstinent Individuals With Heroin Use Disorder: A Double-Blind Randomized Placebo-Controlled Trial

    FavorávelEnsaio Clínico Duplo-CegoDependência QuímicaDependência — Opioides
  40. 2019

    Cannabidiol improves metabolic dysfunction in middle-aged diabetic rats submitted to a chronic cerebral hypoperfusion

    FavorávelEstudo em AnimaisDoenças Cardiovasculares (DCV)Diabetes
  41. 2019

    Cannabidiol in Anxiety and Sleep: A Large Case Series

    FavorávelMetanáliseAnsiedadeInsônia e Distúrbios do Sono
  42. 2019

    Cannabidiol in patients with Lennox-Gastaut syndrome: Interim analysis of an open-label extension study

  43. 2019

    Cannabidiol in the Treatment of Post-Traumatic Stress Disorder: A Case Series

    FavorávelMetanáliseAnsiedadeDepressãoDisfunção Cognitiva+4
  44. 2019

    Cannabidiol induces antidepressant and anxiolytic-like effects in experimental type-1 diabetic animals by multiple sites of action

    FavorávelEstudo em AnimaisAnsiedadeDepressãoDiabetes
  45. 2019

    Cannabidiol Induces Cell Cycle Arrest and Cell Apoptosis in Human Gastric Cancer SGC-7901 Cells

    FavorávelEstudo LaboratorialCâncerCâncer — Estômago
  46. 2019

    Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain

    FavorávelEstudo em AnimaisDorAnsiedadeDepressãoCanabinoides Sintéticos AM-x
  47. 2019

    Cannabidiol partially blocks the sleepiness in hypocretin-deficient rats: Preliminary data

    FavorávelEstudo em AnimaisInsônia e Distúrbios do Sono
  48. 2019

    Cannabidiol prevents LPS-induced microglial inflammation by inhibiting ROS/NF-κB-dependent signaling and glucose consumption

    FavorávelEstudo LaboratorialInflamaçãoEstresse Oxidativo
  49. 2019

    Cannabidiol Protects Dopaminergic Neuronal Cells from Cadmium

    FavorávelEstudo LaboratorialDoenças Neurodegenerativas
  50. 2019

    Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors

  51. 2019

    Cannabidiol reduces seizures following CNS infection with Theiler's murine encephalomyelitis virus

    FavorávelEstudo em AnimaisEncefalite e Mielite
  52. 2019

    Cannabidiol Regulates the Expression of Keratinocyte Proteins Involved in the Inflammation Process through Transcriptional Regulation

    FavorávelEstudo LaboratorialQueimadura Solar
  53. 2019

    Cannabidiol Reverses Deficits in Hippocampal LTP in a Model of Alzheimer’s Disease

    FavorávelEstudo LaboratorialDoença de Alzheimer
  54. 2019

    Cannabidiol Treatment Might Promote Resilience to Cocaine and Methamphetamine Use Disorders: A Review of Possible Mechanisms

  55. 2019

    Cannabidiol-induced Apoptosis Is Mediated by Activation of Noxa in Human Colorectal Cancer Cells

    FavorávelEstudo LaboratorialCâncerCâncer — Cólon
  56. 2019

    Cannabidiol-loaded microspheres incorporated into osteoconductive scaffold enhance mesenchymal stem cell recruitment and regeneration of critical-sized bone defects

    FavorávelEstudo em AnimaisOsteoporoseFraturas Ósseas
  57. 2019

    Cannabidiol, a safe and non-psychotropic ingredient of the marijuana plant Cannabis sativa, is protective in a murine model of colitis.

  58. 2019

    Cannabidiol, cannabinol and their combinations act as peripheral analgesics in a rat model of myofascial pain

  59. 2019

    Cannabidiol: A New Hope for Patients With Dravet or Lennox-Gastaut Syndromes

  60. 2019

    Cannabidiol: A Review of Clinical Efficacy and Safety in Epilepsy

  61. 2019

    Cannabidivarin completely rescues cognitive deficits and delays neurological and motor defects in male Mecp2 mutant mice

  62. 2019

    Cannabinoid 2 Receptor-Based Modulation of the Immune Response in Experimental Models of CNS Injury

  63. 2019

    Cannabinoid as Beneficial Replacement Therapy for Psychotropics to Treat Neuropsychiatric Symptoms in Severe Alzheimer's Dementia: A Clinical Case Report

    FavorávelMetanáliseDoença de AlzheimerTHC Farmacêutico
  64. 2019

    Cannabinoid Attenuation of Intestinal Inflammation in Chronic SIV-Infected Rhesus Macaques Involves T Cell Modulation and Differential Expression of Micro-RNAs and Pro-inflammatory Genes

  65. 2019

    Cannabinoid derivatives acting as dual PPARγ/CB2 agonists as therapeutic agents for systemic sclerosis

  66. 2019

    Cannabinoid drugs: will they relieve or exacerbate tinnitus?

    InconclusivoMetanáliseZumbido
  67. 2019

    Cannabinoid exposure during pregnancy and its impact on immune function

    DesfavorávelMetanáliseGestação
  68. 2019

    Cannabinoid hyperemesis syndrome: A case study and discussion

    InconclusivoMetanáliseSíndrome da Hiperêmese Canabinoide
  69. 2019

    Cannabinoid hyperemesis syndrome: a review of the literature

    InconclusivoMetanáliseSíndrome da Hiperêmese Canabinoide
  70. 2019

    Cannabinoid hyperemesis syndrome: An unrecognized cause of nausea and vomiting

    DesfavorávelMetanáliseSíndrome da Hiperêmese Canabinoide
  71. 2019

    Cannabinoid Hyperemesis Syndrome: Reports of Fatal Cases

    DesfavorávelMetanáliseSíndrome da Hiperêmese Canabinoide
  72. 2019

    Cannabinoid interventions for PTSD: Where to next?

    FavorávelMetanáliseTEPT
  73. 2019

    Cannabinoid modulation of opioid analgesia and subjective drug effects in healthy humans

  74. 2019

    Cannabinoid receptor down-regulation in the ventral cochlear nucleus in a salicylate model of tinnitus

    InconclusivoEstudo em AnimaisZumbido
  75. 2019

    Cannabinoid Receptor Type 1 and Its Role as an Analgesic: An Opioid Alternative?

  76. 2019

    Cannabinoid receptors as therapeutic targets for autoimmune diseases: where do we stand?

  77. 2019

    Cannabinoid Receptors Signaling in the Development, Epigenetics, and Tumours of Male Germ Cells

    InconclusivoMetanáliseCâncerCâncer — Testículo
  78. 2019

    Cannabinoid Regulation of Fear and Anxiety: an Update

    FavorávelMetanáliseAnsiedadeAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+2
  79. 2019

    Cannabinoid Signaling in the Skin: Therapeutic Potential of the “C(ut)annabinoid” System

  80. 2019

    Cannabinoid therapy in epilepsy

  81. 2019

    Cannabinoid toxicity in pediatrics

    DesfavorávelMetanáliseEfeitos Adversos da CannabisAnsiedadeDisfunção Cognitiva+1
  82. 2019

    Cannabinoid type-1 Receptor Blockade Restores Neurological Phenotypes in Two Models for Down Syndrome

    FavorávelEstudo em AnimaisSíndrome de Down
  83. 2019

    Cannabinoid Use in Patients With Gastroparesis and Related Disorders: Prevalence and Benefit

    FavorávelMetanáliseGastroparesiaTHC Farmacêutico
  84. 2019

    Cannabinoid-induced increase of quantal size and enhanced neuromuscular transmission

    FavorávelEstudo em AnimaisMiastenia GravisCanabinoides Sintéticos WIN-x
  85. 2019

    Cannabinoid-sensitive receptors in cardiac physiology and ischaemia

    FavorávelMetanáliseDoenças Cardiovasculares (DCV)Hipertensão ArterialInfarto+2
  86. 2019

    Cannabinoids and bone regeneration

    FavorávelMetanáliseFraturas ÓsseasAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+4
  87. 2019

    Cannabinoids and Dementia: A Review of Clinical and Preclinical Data

  88. 2019

    Cannabinoids and inflammation: Implications for People Living with HIV

    InconclusivoMetanáliseInflamaçãoHIV/AIDS
  89. 2019

    Cannabinoids as a Potential New and Novel Treatment for Melanoma: A Pilot Study in a Murine Model

    FavorávelEstudo em AnimaisCâncerCâncer — Melanoma
  90. 2019

    Cannabinoids determination in bronchoalveolar lavages of cannabis smokers with lung disease

    InconclusivoEstudo LaboratorialTosseBronquiteCanabinol (CBN)
  91. 2019

    Cannabinoids for drug-resistant seizures in a critically ill patient-Case report and literature review

    FavorávelMetanáliseEpilepsiaEpilepsia — Lennox-Gastaut
  92. 2019

    Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis

    InconclusivoMetanáliseAnsiedadeDepressãoPsicose+3
  93. 2019

    Cannabinoids in Breast Cancer: Differential Susceptibility According to Subtype

    FavorávelMetanáliseCâncerCâncer — MamaEndocanabinoide (não especificado)
  94. 2019

    Cannabinoids in depressive disorders

    FavorávelMetanáliseDepressão
  95. 2019

    Cannabinoids in the treatment of rheumatic diseases: Pros and cons

    FavorávelMetanáliseArtriteArtrite — ReumatoideLúpus
  96. 2019

    Cannabinoids induce latent sensitization in a preclinical model of medication overuse headache

    DesfavorávelEstudo em AnimaisEnxaquecaCanabinoides Sintéticos WIN-x
  97. 2019

    Cannabinoids Reduce Inflammation but Inhibit Lymphocyte Recovery in Murine Models of Bone Marrow Transplantation

    FavorávelEstudo em AnimaisInflamaçãoRejeição de Transplante
  98. 2019

    Cannabinoids, cannabis, and cannabis-based medicine for pain management: a protocol for an overview of systematic reviews and a systematic review of randomised controlled trials

    InconclusivoMetanálise ClínicaDorDor — Crônica
  99. 2019

    Cannabinoids, Pain, and Opioid Use Reduction: The Importance of Distilling and Disseminating Existing Data

    InconclusivoMetanáliseDorDor — CrônicaDependência — Opioides+1
  100. 2019

    Cannabinoids: a new approach for pain control?

    FavorávelMetanáliseDorDor — Oncológica